Summary
We tested the notion that oxidative stress makes an important contribution to the aetiology of diabetic neuropathy. The effect of treatment with a 1% dietary supplement of the anti-oxidant butylated hydroxytoluene was studied during 2 months of streptozotocin-induced diabetes mellitus. In final experiments, sciatic motor and saphenous sensory conduction velocities were measured in vivo, and resistance to hypoxic conduction failure for sciatic trunk was examined in vitro. There were 20% and 12% decreases in motor and sensory conduction velocity, respectively after 2 months of diabetes (p<0.001). These were completely prevented by butylated hydroxytoluene treatment (p<0.001). Resistance to hypoxic conduction failure, shown by the time taken for sciatic compound action potential amplitude to decline by 80%, was 55% increased by diabetes, and this was limited to 31% (p<0.01) by treatment. There were no significant effects of treatment on the 9–10 fold elevation of sciatic nerve sorbitol and fructose levels with diabetes, or on the non-significant 22% reduction in myoinositol content. Butylated hydroxytoluene treatment also did not affect sciatic nerve capillary density. We conclude that oxidative stress makes an important contribution to the aetiology of early experimental diabetic neuropathy. Amelioration of oxidative stress could potentially be a final common mechanism whereby a number of diverse treatments exert a beneficial effect on diabetic nerve function.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950
Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8
Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA (1991) Effects of chronic α-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na+-K+-ATPase activity, and vascular supply in STZ-D rats. Diabetes 40: 1652–1658
Cameron NE, Cotter MA, Robertson S (1992) Angiotensin converting enzyme inhibition prevents the development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 35: 12–18
Hotta N, Kakuta H, Fukasawa H et al. (1992) Effect of niceritol on streptozocin-induced diabetic neuropathy in rats. Diabetes 41: 587–591
Cameron NE, Cotter MA, Robertson S (1989) Chronic low frequency electrical activation for one week corrects nerve conduction deficits in rats with diabetes of three months duration. Diabetologia 32: 759–761
Cameron NE, Cotter MA, Robertson S (1991) Essential fatty acid diet supplementation: effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40: 532–539
Julu POO (1990) γ-linolenic acid: a novel remedy for diabetic neuropathy in experimental animals. In: Horrobin DF (ed) Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. Liss, New York, pp 465–476
Tomlinson DR, Robinson JP, Compton AM, Keen P (1989) Essential fatty acid treatment — effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia 32: 655–659
Kihara M, Schmelzer JD, Poduslo JF, Curran FF, Nickander KK, Low PA (1991) Aminoguanidine effect on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 88: 6107–6111
Cameron NE, Cotter MA, Dines K, Love A (1992) Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35: 946–950
Mayer JH, Tomlinson DR (1983) Prevention of defects in axonal transport and nerve conduction by oral administration of myoinositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25: 433–438
Cameron NE, Cotter MA, Robertson S (1989) The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q J Exp Physiol 74: 917–926
Baynes JW (1991) Role of oxidative stress in the development of complications in diabetes. Diabetes 40: 405–412
Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87: 432–438
Kumari K, Umar S, Bansal V, Sahib MK (1991) Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes 40: 1079–1084
Corbett JA, Tilton RG, Chang K et al. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552–556
Lattimer SA, Sima AAF, Greene DA (1989) In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists. Am J Physiol 256: E264-E269
Lambourne JE, Brown AM, Calcutt N, Tomlinson DR, Willars GB (1988) Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition. Diabetologia 31: 379–384
Sredy J, Flam BR, Sawicki DR (1991) Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effects of aldose reductase inhibitors. Proc Soc Exp Biol Med 197: 135–142
Yasuda H, Sonobe M, Yamashita M et al. (1989) Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats comparison with aldose reductase inhibitor ONO 2235. Diabetes 38: 832–838
Cameron NE, Cotter MA (1992) Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway activity. Diabetologia 35: 1011–1019
Schmelzer JD, Zochodne DW, Low PA (1989) Ischemic and reperfusion injury of rat peripheral nerve. Proc Natl Acad Sci USA 86: 1639–1642
McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 312: 159–163
Kashiwagi A, Kikkawa R (1992) Abnormal glutathione redox cycle in cultured human endothelial cells for the pathogenesis of diabetic vascular complications. In: Rifkin H, Colwell JA, Taylor SI (eds) Diabetes 1991, proceedings of the 14th International Diabetes Federation Congress, Washington DC, 23–28 June 1991. Excerpta Medica, Amsterdam, New York, pp 679–682
Loven DH, Schedl H, Wilson H et al. (1986) Effects of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozotocin-induced diabetes. Diabetes 35: 503–507
Low PA, Nickander KK (1991) Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40: 873–877
Creighton MO, Trevithick JR (1979) Cortical cataract formation prevented by vitamin E and glutathione. Exp Eye Res 29: 689–693
Trevethick JR, Creighton MO, Ross WM, Stewart-DeHaan JP, Sanwal M (1981) Modelling cortical cataractogenesis II. In vitro effects on the lens of agents preventing glucose and sorbitol-induced cataracts. Can J Opthalmol 16: 32–38
Ross WM, Creighton MO, Trevithick JR, Stewart-DeHaan JP, Sanwal M (1983) Modelling cortical cataractogenesis IV. Induction by glucose in vitro or in diabetic rats: prevention and reversal by glutathione. Exp Eye Res 37: 559–573
Srivastava SK, Ansari NH (1988) Prevention of sugar-induced cataractogenesis in rats by butylated hydroxytoluene. Diabetes 37: 1505–1508
Wilson GL, Patton NJ, McCord JM, Mullins DW, Mossman BT (1984) Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells. Diabetologia 27: 587–591
Stribling D, Mirrlees DJ, Harrison HE, Earl DCN (1985) Properties of ICI 128,436, a novel aldose reductase inhibitor and its effects on diabetic complications in the rat. Metabolism 34: 336–344
Seneviratne KN, Peiris OA (1969) The effects of hypoxia on the excitability of the isolated peripheral nerves of alloxan-diabetic rats. J Neurol Neurosurg Psychiat 32: 462–469
Bravenboer B, Kapelle AC, Hamers FPT, van Buren T, Erkelens DW, Gispen WH (1992) Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 35: 813–817
Greene DA, De Jesus PV, Winegrad AI (1975) Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest 55: 1326–1336
Eliasson SG (1964) Nerve conduction changes in experimental diabetes. J Clin Invest 43: 2352–2358
Suzuki K, Saito N, Sakata Y, Toyota T, Goto Y (1990) A new prostaglandin E1 analogue (TFC-612) improves the reduction in motor nerve conduction velocity in spontaneously diabetic GK (Goto-Kakizaki) rats. Prostaglandins 40: 463–471
Sima AAF, Prashar A, Zhang W-X, Chakrabarti S, Greene DA (1990) Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. J Clin Invest 85: 1410–1420
Robertson S, Cameron NE, Cotter MA, Dines K (1992) Time-course of reversal of nerve conduction deficits by aldose reductase inhibition-, evening primrose oil, chronic electrical stimulation, and angiotensin converting enzyme inhibition in streptozotocindiabetic rats. Diabetic Med 9 [Suppl 2]: P58 (Abstract)
Cotter MA, Cameron NE, Robertson S (1991) Effects of increased electrical activity on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 34 [Suppl 2]: A50 (Abstract)
Price DE, Airey CM, Alani SM, Wales JK (1988) Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes. Diabetes 37: 969–973
Cameron NE, Cotter MA (1992) Dissociation between biochemical and functional effects of the aldose reductase inhibitor ponalrestat on peripheral nerve in diabetic rats. Br J Pharmacol 107: 939–944
Lockett MJ, Tomlinson DR (1992) The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats. Br J Pharmacol 105: 355–360
Low PA, Tuck RR, Takeuchi M (1987) Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 266–278
Pette D, Smith ME, Staudte HW, Vrbová G (1973) Effects of long-term electrical stimulation on some contractile and metabolic characteristics of fast and slow rabbit muscles. Pflügers Archiv 378: 251–257
Reed DJ (1990) Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 30: 603–631
Vlassara H, Brownlee M, Cerami A (1983) Excessive non enzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 32: 670–674
Cullum NA, Mahon J, Stringer K, McLean WG (1991) Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia 34: 387–389
Andrews HE, Brukdorfer KR, Dunn RC, Jacobs M (1987) Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature 327: 237–239
Morel DW, Chisolm G (1989) Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30: 1827–1834
Evensen SA, Galdal KS, Nilsen E (1983) LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts. Atherosclerosis 49: 23–30
Lyons TJ (1991) Oxidised low density lipoproteins — a role in the pathogenesis of atherosclerosis in diabetes. Diabetic Med 8: 411–419
Moore SA, Bohlen HG, Miller BG, Evan AP (1985) Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats. Blood Vessels 22: 265–277
Peiper GM, Gross GJ (1988) Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 255: H825-H833
Kamata K, Miyata N, Kasuya Y (1989) Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 97: 614–618
Oyama Y, Kawasaki H, Hattori Y, Kanno M (1986) Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 131: 75–78
Ward KK, Low PA, Schmelzer JD, Zochodne DW (1989) Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 112: 197–208
Lands WEM (1985) Mechanisms of action of anti-inflamatory drugs. Adv Drug Res 14: 147–163
Gryglewski RJ, Palmer RMJ, Moncado S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454–456
Hattori Y, Kawasaki H, Kazuhiro A, Kanno M (1991) Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261: H1086-H1094
Kiff RJ, Gardiner SM, Compton AM, Bennett T (1991) The effects of endothelin-1 and NG-nitro-l-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103: 1321–1326
Kiff RJ, Gardiner SM, Compton AM, Bennett T (1991) Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103: 1357–1362
Morff RJ (1990) Microvascular reactivity to norepinephrine at different arteriolar levels and durations of streptozocin-induced diabetes. Diabetes 39: 354–360
Tomlinson KC, Gardiner SM, Hebden RA, Bennett T (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44: 103–150
Monafo WM, Eliasson SG, Shimazaki S, Sugimoto H (1988) Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp Neurol 99: 607–614
Picard S, Parthasarathy S, Fruebis J, Witztum JL (1992) Aminoguanidine (AMGN) inhibits LDL oxidative modification. Diabetes 41 [suppl 1]: 17A (Abstract)
Davidson WS, Murphy DG (1985) Aldehyde reductases and their involvement in muscular dystrophy. In: Flynn G (ed) Enzymology of carbonyl metabolism 2: aldehyde dehydrogenase, aldo-keto reductase and alcohol dehydrogenase. Liss, New York, pp 251–263
Griffith TM, Edwards DH, Newby AC, Lewis MJ, Henderson AH (1986) Production of endothelium-derived relaxant factor is dependent on oxidative phosphorylation and extracellular calcium. Cardiovasc Res 20: 7–12
Weir CJ, Gibson IF, Martin W (1991) Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilation of rat and rabbit aorta. Br J Pharmacol 102: 162–166
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cameron, N.E., Cotter, M.A. & Maxfield, E.K. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36, 299–304 (1993). https://doi.org/10.1007/BF00400231
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400231